WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.66%)Nav, as on 14-10-2025

  • Previous Nav

  • Net Change on 14-10-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 -2.67 22.21 16.99 1.82 8,113.59
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 3.24 28.40 20.07 1.87 6,226.82
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 2.81 25.76 18.86 1.93 3,933.26
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 -1.89 22.87 17.27 2.11 1,295.83
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 0.95 25.10 17.28 2.26 1,096.95

Fund Holdings as on 30-September-2025

  • Clearing Corporation of India Ltd

  • JB Chemicals & Pharmaceuticals Limited

  • Sun Pharmaceutical Industries Limited

  • Fortis Healthcare Limited

  • Cipla Limited

  • Laurus Labs Limited

  • Krishna Institute Of Medical Sciences Limited

  • Neuland Laboratories Limited

  • Max Healthcare Institute Limited

  • Lupin Limited

  • Apollo Hospitals Enterprise Limited

  • Sai Life Sciences Limited

  • Divi's Laboratories Limited

  • Vijaya Diagnostic Centre Limited

  • Abbott India Limited

  • Gland Pharma Limited

  • Shaily Engineering Plastics Limited

  • Ajanta Pharma Limited

  • Jupiter Life Line Hospitals Limited

  • Kovai Medical Center and Hospital Limited

  • Mankind Pharma Limited

  • Glenmark Pharmaceuticals Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Anthem Biosciences Limited

  • Pfizer Limited

  • AstraZeneca Pharma India Limited

  • Alembic Pharmaceuticals Limited

  • Emcure Pharmaceuticals Limited

  • Eris Lifesciences Limited

  • Thyrocare Technologies Limited

  • 91 Days Tbill (MD 02/10/2025)

  • 364 Days Tbill (MD 18/12/2025)

  • Poly Medicure Limited

  • Acutaas Chemicals Limited

  • Healthcare Global Enterprises Limited

  • Dr.Agarwals Eye Hospital Limited

  • Supriya Lifescience Limited

  • Navin Fluorine International Limited

  • Shilpa Medicare Limited

  • 182 Days Tbill (MD 25/12/2025)

  • Aster DM Healthcare Limited

  • Zota Health Care Limited

  • Piramal Pharma Limited

  • PB Fintech Limited

  • Jubilant Ingrevia Limited

  • 364 Days Tbill (MD 03/10/2025)

  • Orchid Pharma Limited

  • 91 Days Tbill (MD 04/12/2025)

  • Onesource Specialty Pharma Limited

  • 91 Days Tbill (MD 30/10/2025)

  • 91 Days Tbill (MD 20/11/2025)

  • 91 Days Tbill (MD 28/11/2025)

  • Laxmi Dental Limited

  • 91 Days Tbill (MD 16/10/2025)

  • 182 Days Tbill (MD 23/10/2025)

  • 91 Days Tbill (MD 23/10/2025)

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Plastic Products

  • Medical Equipment/Supplies/Accessories

  • Chemicals

  • Fintech

View More

Fund Manager

  • Cash

  • Equity

  • Sovereign

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹442.67 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended down ₹-0.09(-0.66%)yesterday to ₹13.95.

Among its top 3 holdings the fund has exposure to Clearing Corporation of India Ltd, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643